Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 3/20 | 0.67 |
| ▸ | CTSK | P43235 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1951088 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| SCHEMBL3825684 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| SCHEMBL3205842 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| SCHEMBL2159319 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| SCHEMBL905289 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| SCHEMBL16710011 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| SCHEMBL12189206 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| SCHEMBL629960 | 1.00 | CTSS (0.67) | CTSSCTSKALDH1A1KMT2APSENEN | |
| Water SCHEMBL5203435 | 0.98 | CTSK (0.69) | CTSSCTSKALDH1A1KMT2APSENEN | |
| Water SCHEMBL10884567 | 0.98 | CTSK (0.69) | CTSSCTSKALDH1A1KMT2APSENEN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 978 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115873034-B | Semi-active phosphoramide ligand and preparation method thereof | 上海毕臣生化科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120136948-A | Cycloastragal derivative with activity of resisting methicillin-resistant staphylococcus aureus and preparation method thereof | 山西医科大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119528812-B | Double amino acid-genipin derivative and preparation method and application thereof | 广东工业大学 | 2025-06-03 | — | — | CN | claimed |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-03-27 | — | — | US | claimed |
| CN-119528812-A | Double amino acid-genipin derivative and preparation method and application thereof | 广东工业大学 | 2025-02-28 | — | — | CN | claimed |
| WO-2025019172-A1 | ANTIMICROBIAL EXTRACTANT FORMED FROM COPPER-CONTAINING SOURCE | CORNING INCORPORATED (US) | 2025-01-23 | — | — | WO | claimed |
| CN-119161284-A | Pleuromutilin derivative with side chain of natural amino acid amidophenyl derivative, and preparation method and application thereof | 华南农业大学 | 2024-12-20 | — | — | CN | claimed |
| CN-118684732-A | Method for preparing AT-01 by liquid phase fragment condensation | 南通大学 | 2024-09-24 | — | — | CN | claimed |
| CN-118085005-A | 18 Beta-glycyrrhetinic acid derivative and preparation method and application thereof | 石河子大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117534721-A | Preparation method of hederagenin derivative | 烟台大学 | 2024-02-09 | — | — | CN | claimed |
| US-20050267104-A1 | E.g., ({[Acetyl({(5R)-3-[4-(1,1-dioxidotetrahydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}-methyl)amino]carbonyl}oxymethyl acetate; these compounds have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria | PHARMACIA & UPJOHN COMPANY LLC | 2005-12-01 | — | — | US | claimed |
| US-6951946-B2 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | LEXICON PHARMACEUTICALS, INC. (US) | 2005-10-04 | — | — | US | claimed |
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | KOLB HARTMUTH C (US) | 2005-07-14 | — | — | US | claimed |
| WO-2005028473-A1 | ACYLOXYMETHYLCARBAMATE PRODRUGS OF OXAZOLIDINONES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2005-03-31 | — | — | WO | claimed |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | LEXICON PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| US-5757408-A | PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING | XEROX CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| EP-0667246-A1 | Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| US-4051171-A | Vinylbenzyl esters of N-BOC-amino acids | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-09-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050267104-A1 | E.g., ({[Acetyl({(5R)-3-[4-(1,1-dioxidotetrahydro-2H-thiopyran4-yl)-3-fluorophenyl]-2-oxo-1,3-oxazolidin-5-yl}-methyl)amino]carbonyl}oxymethyl acetate; these compounds have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria | HDAC3, HDAC1, OGA | CTSS 3028/4885CTSK 1988/4885ALDH1A1 591/4885 |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | CYP11A1, CYP11B1, CYP11B2 | CTSS 728/4885CTSK 1742/4885ALDH1A1 1161/4885 |
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | CTSS 2627/4885CTSK 2356/4885ALDH1A1 85/4885 |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | CTSS 2627/4885CTSK 2356/4885ALDH1A1 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.